Great West Life Assurance CO Rubius Therapeutics, Inc. Transaction History

Great West Life Assurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.79 - $5.98 $1,784 - $13,508	-2,259 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$4.65 - $6.25 $10,109 - $13,587	2,174 Added 2557.65%	2,259 $11,000
Q3 2020 Nov 13, 2020	SELL	$4.65 - $6.25 $10,109 - $13,587	-2,174 Reduced 96.24%	85 $0
Q4 2019 Feb 11, 2020	BUY	$7.23 - $14.12 $16,332 - $31,897	2,259 New	2,259 $21,000
Q3 2019 Oct 25, 2019	SELL	$7.85 - $15.75 $33,417 - $67,047	-4,257 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$13.5 - $19.94 $57,469 - $84,884	4,257 New	4,257 $0

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.